Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.

Biotechnology

Interius Biotherapeutics

Phil Johnson

Philip R. Johnson M.D.

The Research & Development team at Interius Biotherapeutics focuses on advancing the company’s innovative cell and gene therapy delivery technologies. Leveraging expertise in high throughput screening and analytics, the team conducts rigorous testing and analysis to optimize therapeutic efficacy and safety, while collaborating closely with advisors to shape the strategic direction of research initiatives.

Research & Development

About

Team members

Other teams at Interius Biotherapeutics

Research and Development

Leadership Team

Research and Development